

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.44245632 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.40580480 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.29110910 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.79456380 |
| 5 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.58665450 |
| 6 | Peyers patch development (GO:0048541) | 4.34644075 |
| 7 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.34644075 |
| 8 | detection of bacterium (GO:0016045) | 4.30673346 |
| 9 | negative T cell selection (GO:0043383) | 4.26105025 |
| 10 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.21488061 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.13806360 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.06001984 |
| 13 | cytidine metabolic process (GO:0046087) | 4.03785313 |
| 14 | cytidine catabolic process (GO:0006216) | 4.03785313 |
| 15 | cytidine deamination (GO:0009972) | 4.03785313 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00076662 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.00076662 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93253588 |
| 19 | detection of other organism (GO:0098543) | 3.88211649 |
| 20 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.75982685 |
| 21 | positive regulation of granulocyte differentiation (GO:0030854) | 3.73709165 |
| 22 | response to type I interferon (GO:0034340) | 3.71807312 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.68280252 |
| 24 | NIK/NF-kappaB signaling (GO:0038061) | 3.67606030 |
| 25 | type I interferon signaling pathway (GO:0060337) | 3.62803946 |
| 26 | cellular response to type I interferon (GO:0071357) | 3.62803946 |
| 27 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.48089776 |
| 28 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45428558 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.41785993 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39548098 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 3.39108884 |
| 32 | thymic T cell selection (GO:0045061) | 3.38414130 |
| 33 | T cell costimulation (GO:0031295) | 3.36024724 |
| 34 | response to muramyl dipeptide (GO:0032495) | 3.35812324 |
| 35 | T cell lineage commitment (GO:0002360) | 3.34705080 |
| 36 | T-helper 1 type immune response (GO:0042088) | 3.33669483 |
| 37 | lymphocyte costimulation (GO:0031294) | 3.31884956 |
| 38 | T cell selection (GO:0045058) | 3.30546989 |
| 39 | positive thymic T cell selection (GO:0045059) | 3.28334627 |
| 40 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.21279519 |
| 41 | negative regulation of myotube differentiation (GO:0010832) | 3.20011951 |
| 42 | positive T cell selection (GO:0043368) | 3.17994347 |
| 43 | angiotensin maturation (GO:0002003) | 3.15531082 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13939536 |
| 45 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.13793723 |
| 46 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.11645781 |
| 47 | mature B cell differentiation involved in immune response (GO:0002313) | 3.06288475 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 3.03280514 |
| 49 | T cell migration (GO:0072678) | 3.02951435 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01614925 |
| 51 | positive regulation by symbiont of host defense response (GO:0052509) | 2.94638345 |
| 52 | modulation by symbiont of host defense response (GO:0052031) | 2.94638345 |
| 53 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.94638345 |
| 54 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.94638345 |
| 55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.94638345 |
| 56 | modulation by symbiont of host immune response (GO:0052553) | 2.94638345 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.94515072 |
| 58 | regulation of interleukin-4 production (GO:0032673) | 2.93750570 |
| 59 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.92017840 |
| 60 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.91413325 |
| 61 | regulation of hypersensitivity (GO:0002883) | 2.88771821 |
| 62 | atrioventricular valve morphogenesis (GO:0003181) | 2.87163027 |
| 63 | B cell proliferation (GO:0042100) | 2.86768063 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85568049 |
| 65 | detection of external biotic stimulus (GO:0098581) | 2.85115789 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 2.82486240 |
| 67 | regulation of granulocyte differentiation (GO:0030852) | 2.81047894 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79360142 |
| 69 | B cell mediated immunity (GO:0019724) | 2.78192196 |
| 70 | urea metabolic process (GO:0019627) | 2.77126529 |
| 71 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76982847 |
| 72 | NADH metabolic process (GO:0006734) | 2.74267466 |
| 73 | coronary vasculature morphogenesis (GO:0060977) | 2.72065496 |
| 74 | cellular response to interferon-gamma (GO:0071346) | 2.71903627 |
| 75 | mature B cell differentiation (GO:0002335) | 2.70177844 |
| 76 | nitrogen cycle metabolic process (GO:0071941) | 2.67420873 |
| 77 | negative regulation of viral genome replication (GO:0045071) | 2.64156902 |
| 78 | regulation of alpha-beta T cell activation (GO:0046634) | 2.64070514 |
| 79 | urea cycle (GO:0000050) | 2.63357213 |
| 80 | cellular response to reactive nitrogen species (GO:1902170) | 2.63081434 |
| 81 | cGMP-mediated signaling (GO:0019934) | 2.62956202 |
| 82 | response to interferon-beta (GO:0035456) | 2.62039734 |
| 83 | positive regulation of interleukin-4 production (GO:0032753) | 2.59391317 |
| 84 | regulation of antigen processing and presentation (GO:0002577) | 2.56573537 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.55506818 |
| 86 | myeloid dendritic cell differentiation (GO:0043011) | 2.54193550 |
| 87 | regulation of cellular extravasation (GO:0002691) | 2.51712406 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 2.51364879 |
| 89 | response to interferon-gamma (GO:0034341) | 2.50183011 |
| 90 | V(D)J recombination (GO:0033151) | 2.48198661 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.47653394 |
| 92 | alkaloid metabolic process (GO:0009820) | 2.47504916 |
| 93 | regulation of germinal center formation (GO:0002634) | 2.46402649 |
| 94 | B cell homeostasis (GO:0001782) | 2.46173463 |
| 95 | positive regulation of antigen processing and presentation (GO:0002579) | 2.45615340 |
| 96 | response to protozoan (GO:0001562) | 2.45162171 |
| 97 | peripheral nervous system neuron development (GO:0048935) | 2.42427877 |
| 98 | T-helper cell differentiation (GO:0042093) | 2.41584270 |
| 99 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.41584270 |
| 100 | positive regulation of interferon-alpha production (GO:0032727) | 2.40771370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.68872852 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.99680301 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.73780748 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.12918070 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.10023130 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.58251600 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.56911669 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.55783611 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.45509773 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.44483903 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 2.34790498 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.34229653 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 2.32014003 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31476512 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.29760035 |
| 16 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.28341703 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20069417 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.18169497 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16449690 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14109425 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12854675 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09718453 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07147495 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06375333 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.05946277 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.03022626 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.96186563 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 1.94021777 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91630651 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.91316248 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90736936 |
| 32 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.85687856 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84563203 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.83318676 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82436309 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82303806 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81157299 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.80024327 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78540241 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72933609 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.71756888 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.71189546 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.70836651 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.69832729 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65941477 |
| 46 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58358505 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53216872 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52140955 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51731472 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51213157 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.48704839 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45306699 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.44676671 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44393400 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42533063 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40957541 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38670126 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38180382 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37930091 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36180571 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35923531 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34133640 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34105365 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.33834414 |
| 65 | SA1_27219007_Chip-Seq_Bcells_Human | 1.28618761 |
| 66 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.26998453 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26336756 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24534806 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22006713 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21366413 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20511875 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14696384 |
| 73 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13637486 |
| 74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11834800 |
| 75 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.11282398 |
| 76 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.09892372 |
| 77 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09122063 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08401421 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07028441 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06799363 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02832447 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01126701 |
| 83 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00609639 |
| 84 | P300_27268052_Chip-Seq_Bcells_Human | 1.00509200 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00481036 |
| 86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99705013 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99043392 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97997301 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97906153 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97738238 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97166219 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96948940 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96540154 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96408068 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94591338 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93894516 |
| 97 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93768879 |
| 98 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.93403020 |
| 99 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.93402124 |
| 100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93209600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.95220477 |
| 2 | MP0005671_abnormal_response_to | 3.45559830 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.35987706 |
| 4 | MP0000685_abnormal_immune_system | 3.29133631 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.95788877 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.83055382 |
| 7 | MP0005387_immune_system_phenotype | 2.77067760 |
| 8 | MP0001790_abnormal_immune_system | 2.77067760 |
| 9 | MP0001800_abnormal_humoral_immune | 2.72151915 |
| 10 | MP0003436_decreased_susceptibility_to | 2.58252774 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.54144158 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.49039132 |
| 13 | MP0004381_abnormal_hair_follicle | 2.41734973 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.36913441 |
| 15 | MP0004510_myositis | 2.19990621 |
| 16 | MP0002723_abnormal_immune_serum | 2.15657771 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.11029335 |
| 18 | MP0003724_increased_susceptibility_to | 2.05036651 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.03913843 |
| 20 | MP0005025_abnormal_response_to | 1.99940364 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.97922409 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.95773461 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.94229662 |
| 24 | MP0009785_altered_susceptibility_to | 1.92271076 |
| 25 | MP0001819_abnormal_immune_cell | 1.91232372 |
| 26 | MP0002006_tumorigenesis | 1.87497189 |
| 27 | MP0003303_peritoneal_inflammation | 1.84672617 |
| 28 | MP0002398_abnormal_bone_marrow | 1.84473674 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.83671466 |
| 30 | MP0000716_abnormal_immune_system | 1.71349238 |
| 31 | MP0009379_abnormal_foot_pigmentation | 1.70614914 |
| 32 | MP0001873_stomach_inflammation | 1.67392638 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.62082169 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.57095700 |
| 35 | MP0002419_abnormal_innate_immunity | 1.55375110 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.51434865 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.50857767 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.49561302 |
| 39 | MP0005451_abnormal_body_composition | 1.49136717 |
| 40 | MP0002405_respiratory_system_inflammati | 1.48495415 |
| 41 | MP0000490_abnormal_crypts_of | 1.40811414 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.39989146 |
| 43 | MP0009840_abnormal_foam_cell | 1.39586835 |
| 44 | MP0002429_abnormal_blood_cell | 1.38463399 |
| 45 | MP0004947_skin_inflammation | 1.34128228 |
| 46 | MP0002722_abnormal_immune_system | 1.33807857 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.31945825 |
| 48 | MP0002132_abnormal_respiratory_system | 1.30425735 |
| 49 | MP0008469_abnormal_protein_level | 1.30095717 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.28420545 |
| 51 | MP0002009_preneoplasia | 1.27936113 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.26248495 |
| 53 | MP0005365_abnormal_bile_salt | 1.25741702 |
| 54 | MP0003252_abnormal_bile_duct | 1.20790288 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.16851201 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.14468837 |
| 57 | MP0002163_abnormal_gland_morphology | 1.11376087 |
| 58 | MP0003866_abnormal_defecation | 1.09343306 |
| 59 | MP0000003_abnormal_adipose_tissue | 1.05745257 |
| 60 | MP0003075_altered_response_to | 1.05542321 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.05001337 |
| 62 | MP0005166_decreased_susceptibility_to | 1.02394242 |
| 63 | MP0005332_abnormal_amino_acid | 0.99121672 |
| 64 | MP0003300_gastrointestinal_ulcer | 0.98781948 |
| 65 | MP0001545_abnormal_hematopoietic_system | 0.95244652 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 0.95244652 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 0.94770156 |
| 68 | MP0001853_heart_inflammation | 0.94707058 |
| 69 | MP0008057_abnormal_DNA_replication | 0.94629925 |
| 70 | MP0003693_abnormal_embryo_hatching | 0.94457123 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.90008905 |
| 72 | MP0002136_abnormal_kidney_physiology | 0.89832673 |
| 73 | MP0003045_fibrosis | 0.89740403 |
| 74 | MP0005310_abnormal_salivary_gland | 0.89313974 |
| 75 | MP0000249_abnormal_blood_vessel | 0.89299173 |
| 76 | MP0009115_abnormal_fat_cell | 0.88310404 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 0.86469913 |
| 78 | MP0005375_adipose_tissue_phenotype | 0.85731856 |
| 79 | MP0000609_abnormal_liver_physiology | 0.84779966 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.83837821 |
| 81 | MP0003868_abnormal_feces_composition | 0.82632559 |
| 82 | MP0006138_congestive_heart_failure | 0.81424644 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.80986330 |
| 84 | MP0002933_joint_inflammation | 0.80892452 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80092337 |
| 86 | MP0008872_abnormal_physiological_respon | 0.79684419 |
| 87 | MP0006082_CNS_inflammation | 0.79247014 |
| 88 | MP0001661_extended_life_span | 0.78549003 |
| 89 | MP0009764_decreased_sensitivity_to | 0.76968069 |
| 90 | MP0008874_decreased_physiological_sensi | 0.76318663 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.75857119 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 0.75334092 |
| 93 | MP0005334_abnormal_fat_pad | 0.74673562 |
| 94 | MP0005448_abnormal_energy_balance | 0.72717330 |
| 95 | MP0000858_altered_metastatic_potential | 0.71994144 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.71604758 |
| 97 | MP0005409_darkened_coat_color | 0.71190321 |
| 98 | MP0009763_increased_sensitivity_to | 0.69891175 |
| 99 | MP0002796_impaired_skin_barrier | 0.69759139 |
| 100 | MP0002971_abnormal_brown_adipose | 0.68527042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgE level (HP:0003212) | 5.24910541 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.40098644 |
| 3 | Malnutrition (HP:0004395) | 4.22715430 |
| 4 | Gastrointestinal stroma tumor (HP:0100723) | 4.06116868 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.56308766 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 3.54545489 |
| 7 | Meningitis (HP:0001287) | 3.48320734 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.35174674 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 3.31094144 |
| 10 | Recurrent viral infections (HP:0004429) | 3.30457407 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.07011614 |
| 12 | Lymphopenia (HP:0001888) | 3.06172547 |
| 13 | Chronic diarrhea (HP:0002028) | 3.04818524 |
| 14 | Vasculitis (HP:0002633) | 3.03893098 |
| 15 | IgA deficiency (HP:0002720) | 3.03517266 |
| 16 | Emphysema (HP:0002097) | 3.03398302 |
| 17 | Combined immunodeficiency (HP:0005387) | 2.97472064 |
| 18 | IgG deficiency (HP:0004315) | 2.92193705 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.86136852 |
| 20 | Abnormality of B cell number (HP:0010975) | 2.84123566 |
| 21 | B lymphocytopenia (HP:0010976) | 2.82068483 |
| 22 | Encephalitis (HP:0002383) | 2.78548272 |
| 23 | Petechiae (HP:0000967) | 2.77531100 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.74754868 |
| 25 | Pustule (HP:0200039) | 2.73652262 |
| 26 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.72772590 |
| 27 | Broad face (HP:0000283) | 2.70038873 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.69147097 |
| 29 | Agammaglobulinemia (HP:0004432) | 2.69133057 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 2.63102489 |
| 31 | Oral leukoplakia (HP:0002745) | 2.56494382 |
| 32 | Alkalosis (HP:0001948) | 2.54510191 |
| 33 | Abnormality of T cells (HP:0002843) | 2.48546691 |
| 34 | Myositis (HP:0100614) | 2.46821537 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.42232515 |
| 36 | Recurrent abscess formation (HP:0002722) | 2.37970452 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.37032217 |
| 38 | Recurrent bronchitis (HP:0002837) | 2.34633981 |
| 39 | Increased IgM level (HP:0003496) | 2.33667372 |
| 40 | Hypergammaglobulinemia (HP:0010702) | 2.33538722 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.33007730 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.32391539 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.31888088 |
| 44 | Orchitis (HP:0100796) | 2.30752180 |
| 45 | Keratoconjunctivitis sicca (HP:0001097) | 2.22428520 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.21998129 |
| 47 | Obstructive lung disease (HP:0006536) | 2.21998129 |
| 48 | Optic neuritis (HP:0100653) | 2.21600904 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.21600904 |
| 50 | IgM deficiency (HP:0002850) | 2.21452465 |
| 51 | Skin ulcer (HP:0200042) | 2.18398179 |
| 52 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.17919047 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17897083 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17897083 |
| 55 | Lymphoma (HP:0002665) | 2.14250732 |
| 56 | Granulocytopenia (HP:0001913) | 2.08389373 |
| 57 | Urticaria (HP:0001025) | 2.07736591 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.05140695 |
| 59 | Hydroxyprolinuria (HP:0003080) | 2.05039022 |
| 60 | Abnormality of proline metabolism (HP:0010907) | 2.05039022 |
| 61 | Fatigue (HP:0012378) | 2.04929077 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.04710558 |
| 63 | Amaurosis fugax (HP:0100576) | 2.03599957 |
| 64 | Macrocytic anemia (HP:0001972) | 2.03427554 |
| 65 | Papilloma (HP:0012740) | 2.03229705 |
| 66 | Verrucae (HP:0200043) | 2.03229705 |
| 67 | Bone cyst (HP:0012062) | 2.02364619 |
| 68 | Hyperparathyroidism (HP:0000843) | 2.01345201 |
| 69 | Cellulitis (HP:0100658) | 2.00023017 |
| 70 | Hypertensive crisis (HP:0100735) | 1.99766151 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 1.98668705 |
| 72 | Keratoconjunctivitis (HP:0001096) | 1.98199780 |
| 73 | Restrictive lung disease (HP:0002091) | 1.97845424 |
| 74 | Colitis (HP:0002583) | 1.97061901 |
| 75 | Hypophosphatemia (HP:0002148) | 1.96477144 |
| 76 | Metabolic alkalosis (HP:0200114) | 1.96408082 |
| 77 | T lymphocytopenia (HP:0005403) | 1.96084268 |
| 78 | Aplasia cutis congenita (HP:0001057) | 1.94786387 |
| 79 | Abnormality of T cell number (HP:0011839) | 1.92714360 |
| 80 | Gastrointestinal infarctions (HP:0005244) | 1.89240188 |
| 81 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89141234 |
| 82 | Hypercortisolism (HP:0001578) | 1.88803400 |
| 83 | Pseudobulbar signs (HP:0002200) | 1.87747798 |
| 84 | Recurrent skin infections (HP:0001581) | 1.87679227 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86580598 |
| 86 | Abnormality of the pleura (HP:0002103) | 1.86485561 |
| 87 | Duplicated collecting system (HP:0000081) | 1.85900034 |
| 88 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.84989229 |
| 89 | Inflammation of the large intestine (HP:0002037) | 1.83753954 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 1.83052802 |
| 91 | Axonal loss (HP:0003447) | 1.80640935 |
| 92 | Hypertriglyceridemia (HP:0002155) | 1.80368724 |
| 93 | Hypercalcemia (HP:0003072) | 1.80299984 |
| 94 | Exocrine pancreatic insufficiency (HP:0001738) | 1.78538056 |
| 95 | Papilledema (HP:0001085) | 1.76658678 |
| 96 | Gangrene (HP:0100758) | 1.76572615 |
| 97 | Hemoptysis (HP:0002105) | 1.74701962 |
| 98 | Nausea (HP:0002018) | 1.74682011 |
| 99 | Recurrent sinusitis (HP:0011108) | 1.74373011 |
| 100 | Chest pain (HP:0100749) | 1.74080673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.72611797 |
| 2 | MAP4K1 | 3.63987511 |
| 3 | PRPF4B | 3.60922516 |
| 4 | RIPK4 | 3.60526893 |
| 5 | TAOK3 | 3.45094275 |
| 6 | ERN1 | 2.76276980 |
| 7 | SIK2 | 2.43041196 |
| 8 | NLK | 2.30383102 |
| 9 | MST1R | 2.14620795 |
| 10 | PDK2 | 2.12920222 |
| 11 | BLK | 2.12468063 |
| 12 | MAP3K10 | 1.86602066 |
| 13 | SMG1 | 1.82578841 |
| 14 | MAPK12 | 1.70283129 |
| 15 | SYK | 1.69517992 |
| 16 | MAPK11 | 1.69358256 |
| 17 | CSK | 1.54981643 |
| 18 | TBK1 | 1.53432671 |
| 19 | MAP3K14 | 1.50201711 |
| 20 | VRK2 | 1.50050534 |
| 21 | BRD4 | 1.50048689 |
| 22 | MAP3K7 | 1.47182155 |
| 23 | ACVR1B | 1.43508147 |
| 24 | CDC42BPA | 1.39880477 |
| 25 | TYK2 | 1.36804031 |
| 26 | NME1 | 1.35699166 |
| 27 | CDK4 | 1.32060508 |
| 28 | HIPK2 | 1.30678316 |
| 29 | MAPK7 | 1.24983615 |
| 30 | BTK | 1.24849733 |
| 31 | TNK2 | 1.23005735 |
| 32 | KIT | 1.19310577 |
| 33 | MAP3K13 | 1.18192059 |
| 34 | IRAK4 | 1.11135808 |
| 35 | IKBKE | 1.10785013 |
| 36 | NEK9 | 1.08841202 |
| 37 | BMPR2 | 1.08816794 |
| 38 | MAPK4 | 1.05191308 |
| 39 | IKBKB | 1.03833444 |
| 40 | TXK | 0.94830548 |
| 41 | SIK1 | 0.94708288 |
| 42 | LYN | 0.88730707 |
| 43 | JAK3 | 0.88427389 |
| 44 | ZAP70 | 0.87821312 |
| 45 | ALK | 0.86594855 |
| 46 | GRK6 | 0.86244903 |
| 47 | TAOK2 | 0.85713952 |
| 48 | MAPKAPK5 | 0.85577715 |
| 49 | MAP3K1 | 0.85156913 |
| 50 | CDK7 | 0.85004143 |
| 51 | MARK2 | 0.83197370 |
| 52 | ITK | 0.83169410 |
| 53 | RIPK1 | 0.82421174 |
| 54 | EPHB1 | 0.79817756 |
| 55 | ICK | 0.79579238 |
| 56 | CDC7 | 0.78118130 |
| 57 | MAP2K2 | 0.77231259 |
| 58 | TAF1 | 0.76236843 |
| 59 | CSF1R | 0.76083367 |
| 60 | PRKCQ | 0.73658326 |
| 61 | LCK | 0.72671541 |
| 62 | HCK | 0.72523249 |
| 63 | TESK2 | 0.71819369 |
| 64 | MELK | 0.71625460 |
| 65 | FGFR4 | 0.70475214 |
| 66 | PIM1 | 0.67320960 |
| 67 | PASK | 0.66471232 |
| 68 | MAPKAPK3 | 0.66289772 |
| 69 | JAK1 | 0.63129206 |
| 70 | DMPK | 0.61713538 |
| 71 | TRPM7 | 0.61589681 |
| 72 | TEC | 0.59677630 |
| 73 | FES | 0.55073491 |
| 74 | TAOK1 | 0.54827357 |
| 75 | TESK1 | 0.54640743 |
| 76 | CAMKK2 | 0.53589589 |
| 77 | MTOR | 0.53412603 |
| 78 | CDK8 | 0.51334129 |
| 79 | NME2 | 0.49829317 |
| 80 | MATK | 0.46336668 |
| 81 | PDK1 | 0.45689416 |
| 82 | PDPK1 | 0.44758305 |
| 83 | FGFR3 | 0.44563138 |
| 84 | TYRO3 | 0.44161673 |
| 85 | DDR2 | 0.41450948 |
| 86 | STK4 | 0.40568528 |
| 87 | CHUK | 0.36476291 |
| 88 | CDK6 | 0.36276966 |
| 89 | MAPK3 | 0.36264667 |
| 90 | STK10 | 0.34250983 |
| 91 | FYN | 0.33935566 |
| 92 | MARK3 | 0.33653707 |
| 93 | MAPKAPK2 | 0.33366278 |
| 94 | JAK2 | 0.33030044 |
| 95 | KDR | 0.32557830 |
| 96 | CDK9 | 0.32500352 |
| 97 | CAMKK1 | 0.32046016 |
| 98 | PDGFRB | 0.30895806 |
| 99 | PTK6 | 0.30715536 |
| 100 | TNIK | 0.30640748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.01849338 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.97233602 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.88544308 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.81808688 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.57673588 |
| 6 | Asthma_Homo sapiens_hsa05310 | 3.57152563 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.21383439 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.49303931 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.34132589 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.32713543 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04605239 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99817258 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90906760 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75929809 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69964247 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.63494839 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.57630337 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44849046 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.42900570 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42037746 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40792798 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.30266471 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26431305 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.26215946 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24788926 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21047191 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20100583 |
| 28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.09761564 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09120988 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07609643 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.07441379 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07032042 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.06615919 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00654337 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.00633262 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98106107 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90467048 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89559259 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86940881 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 0.83349076 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82936043 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81068084 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79032110 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75690652 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75644869 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75070353 |
| 47 | Mineral absorption_Homo sapiens_hsa04978 | 0.74716812 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73343587 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72252644 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70155603 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 0.69589872 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67304444 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67202981 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66246894 |
| 55 | Ribosome_Homo sapiens_hsa03010 | 0.64648405 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.63318833 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58608457 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57664305 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57631118 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57045227 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56900112 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56488006 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.55777265 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.53713105 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53625983 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53146842 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53084111 |
| 68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50344330 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49553737 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48961161 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48724134 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47963793 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.45873798 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45365317 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44933427 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44772542 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44256873 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43905482 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.42903517 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.42281439 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42250695 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41932264 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 0.40372085 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38902490 |
| 85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38265561 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.37898831 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37880550 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37201936 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36939393 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.35232103 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.34760417 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33596197 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32403910 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.32223182 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.31813462 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29428198 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.26166544 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24110601 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.23862432 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23366967 |

